Fucun Xie

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Decoding the SHOX2 methylation-expression paradox in lung adenocarcinoma: Dual-regulatory methylation patterns drive oncogenic activation and prognostic relevance.

Decoding the SHOX2 methylation-expression paradox in lung adenocarcinoma: Dual-regulatory methylation patterns drive oncogenic activation and prognostic relevance.

Journal: Cancer letters

Published: September 06, 2025

Lung cancer associated transcript 1 binds heat shock protein 90 to promote growth of hepatocellular carcinoma.

Lung cancer associated transcript 1 binds heat shock protein 90 to promote growth of hepatocellular carcinoma.

Journal: Cellular signalling

Published: November 05, 2024

Identification and validation of the association of Janus kinase 2 mutations with the response to immune checkpoint inhibitor therapy.

Identification and validation of the association of Janus kinase 2 mutations with the response to immune checkpoint inhibitor therapy.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: July 02, 2023

HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinoma.

HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinoma.

Journal: Clinical epigenetics

Published: December 01, 2022

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients.

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients.

Journal: Hepatology international

Published: October 11, 2022

Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinoma.

Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: September 24, 2022

Diagnostic and prognostic potential of methylated septin 9 needs more evidence in hepatocellular carcinoma.

Diagnostic and prognostic potential of methylated septin 9 needs more evidence in hepatocellular carcinoma.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: June 12, 2022

Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon Adenocarcinoma.

Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon Adenocarcinoma.

Journal: Frontiers in cell and developmental biology

Published: April 01, 2022

Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers.

Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers.

Journal: Journal for immunotherapy of cancer

Published: November 04, 2021

Surgical strategies for patients with second primary non-small cell lung cancer lesions 2 cm or less in diameter.

Surgical strategies for patients with second primary non-small cell lung cancer lesions 2 cm or less in diameter.

Journal: Surgery today

Published: September 21, 2021

Differential genes and scoring criteria among immunogenomic clusters of lower-grade gliomas.

Differential genes and scoring criteria among immunogenomic clusters of lower-grade gliomas.

Journal: International immunopharmacology

Published: August 16, 2021

Comparison of Therapy in Advanced Hepatocellular Carcinoma Based on Clear Definition and Accurate Subgroup Data.

Comparison of Therapy in Advanced Hepatocellular Carcinoma Based on Clear Definition and Accurate Subgroup Data.

Journal: JAMA oncology

Published: April 08, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026